维普中文期刊产品整合服务
27篇 您的检索式:作者名="SEIBEL NL"
    题名 作者 年代 出处 被引量
1Pharmacokinetics safety,and tolerability of caspofungin in children and adoles cents显示文摘Walsh TJ Adamson PC Seibel NL 2005Antimicrob Agents Chemother2005,49,11:1
2Outcomes for children and adolescents with cancer: challenges for the twenty-first century 显示文摘Smith MA Seibel NL Altekruse SF 2010J Clin Oncol2010,28,15:1
3PhaseⅠstudy of gemcitabine(difluorodeoxycytidine)in children with relapsed or refractory leukemia(CCG-0955):a report from the Children's Cancer Group显示文摘Steinherz PG Seibel NL Ames MM et a1 2002Leuk lymphoma2002,43,10:1
4Phase Ⅰ study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group 显示文摘 Seibel NL Ames MM 2002Leuk Lymphoma2002,43,10:1
5Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients显示文摘SEIBEL NL SCHWARTZ C ARRIETA A 2005Antimicrob Agents Chemo- ther2005,49,8:1
6Aprepitant use in children, adolescents, and young adults for the control of chemotherapy- induced nausea and vomiting (CINV)显示文摘Choi MR Jiles C Seibel NL 2010J Pediatr Hematol Oncol2010,32,7:1
7Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents 显示文摘Walsh TJ Adamson PC Seibel NL 2005Antimicrob Agents Chemother2005,49,11:1
8Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections 显示文摘Benjamin DK Jr Driseoll T Seibel NL 2006Antimierob Agents Chemother2006,50,2:1
9Amphotericin B lipid complex for invasive fungal infections:analysis of safety and efficacy in 556 cases显示文摘Walsh TJ Hiemenz JW Seibel NL 1998Clin Infect Dis1998,26,6:1
10PhaseⅠstudy ofgemcitabine(difluorodeoxycytidine)in children with relapsed orrefractory leukemia(CCG-0955):a report from the Children's CancerGroup显示文摘Steinherz PG Seibel NL Ames MM 2002Leuk lymphoma2002,43,10:1
11Pharmacokinetics,safety,and tolerability of caspofungin in children and adolescents显示文摘Walsh TJ Adamson PC Seibel NL 2005Antimicrob Agents Chemother2005,49,11:1
12Asparaginaseantibody and asparaginase activity in children with higher-risk a-cute lymphoblastic leukemia : Children , s Cancer Group StudyCCG-1961 显示文摘Panosyan EH Seibel NL Martin-Aragon S 2004J Pediatr Hematol Oncol2004,26,4:1
13Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia:Children's Cancer Group Study CCG-1961显示文摘Panosyan EH Seibel NL Martin-Aragon S 2004J Pediatr Hematol Oncol2004,26,4:1
14Pharmacokinetics, safety,and tolerability of caspofungin in children and adolescents 显示文摘Walsh TJ Adamson PC Seibel NL 2005Antimicrob Agents Chemother2005,49,1:1
15Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children' s Cancer Group Study CCG- 1961 显示文摘Panosyan EH Seibel NL Martin-Aragon S 2004J Pediatr Hematol Oncol2004,26,4:1
16Safety,tolerability,and pharmacokinetics of Micafungin (FK463) in febrile noutropenic pediatric patients显示文摘Seibel NL Schwartz C Arrieta A 2005Antimicrob Agents Chemother2005,49,:1
17Outcomes for childrenand adolescents with cancer : challenges for the twenty-first century显示文摘Smith MA Seibel NL Altekruse SF 2010J Clin Oncol2010,28,15:1
18Treatment of acute lymphoblastic leukemia in children and adolescents: peaks and pitfalls显示文摘Seibel NL 2008Hematology Am Sco Hematol Educ Program2008,,:1
19Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group显示文摘Seibel NL Steinherz PG Sather HN 2008Blood2008,111,5:1
20Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections显示文摘Wiley JM Seibel NL Walsh TJ 2005Pediatr Infect Dis J2005,24,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费